C22H27FN4O2.C4H6O5
Neat
532.56
Sunitinib Malate
+5°C
Room Temperature
(2S)-2-Hydroxybutanedioic acid compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1, 2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2, 4-dimethyl-1H-pyrrole-3-carboxamide (1:1), Butanedioic acid, hydroxy-, (2S)-, compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1, 2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2, 4-dimethyl-1H-pyrrole-3-carboxamide (1:1) (9CI), 1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1, 2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2, 4-dimethyl-, (2S)-hydroxybutanedioate (1:1) (9CI), SU 011248, SU 11248, Sunitinib L-malate, Sunitinib malate and Sutent
CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C.O[C@@H](CC(=O)O)C(=O)O
N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2 and 4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid